The application of information technology to regional, national, and global surveillance of antimicrobial Resistance : Infectious DiseasesSAHM, Daniel F; THORNSBERRY, Clyde; KARLOWSKY, James A et al.Current pharmaceutical design. 2003, Vol 9, Num 12, pp 969-974, issn 1381-6128, 6 p.Article

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoinKARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 2, pp 183-187, issn 1058-4838, 5 p.Article

Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001KARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1672-1680, issn 0066-4804, 9 p.Article

In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendationsSAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 2, pp 669-674, issn 0095-1137Article

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2540-2545, issn 0066-4804Article

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicleMILLS, Otto JR; THORNSBERRY, Clyde; CARDIN, Caroline W et al.Acta dermato-venereologica. 2002, Vol 82, Num 4, pp 260-265, issn 0001-5555, 6 p.Article

Multidrug-resistant urinary tract isolates of Escherichia coli : Prevalence and patient demographics in the United States in 2000SAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 5, pp 1402-1406, issn 0066-4804Article

Legionella, proceedings of the 2nd international symposium, (Washington DC), [1983]Jakubowski, Walter; Feeley, James C; Balows, Albert et al.Legionella. International symposium. 1984, XIII-371 p, isbn 0-914826-58-1Conference Proceedings

Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaKARLOWSKY, James A; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 7, pp 3339-3343, issn 0095-1137, 5 p.Article

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the Trust Surveillance Program (1998-2002)KARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 8, pp 963-970, issn 1058-4838, 8 p.Article

Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001KARLOWSKY, James A; DRAGHI, Deborah C; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1681-1688, issn 0066-4804, 8 p.Article

Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000-2001CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1689-1693, issn 0066-4804, 5 p.Article

Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: Results from 2000-2001 and 2001-2002 TRUST studies in the United StatesKARLOWSKY, James A; THORNSBERRY, Clyde; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 6, pp 1790-1797, issn 0066-4804, 8 p.Article

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999CRITCHLEY, Ian A; SAHM, Daniel F; THORNSBERRY, Clyde et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 2, pp 129-135, issn 0732-8893Article

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2002, Vol 19, Num 1, pp 21-31, issn 0924-8579Article

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002FLAMM, Robert K; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 7, pp 2431-2436, issn 0066-4804, 6 p.Article

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001CRITCHLEY, Ian A; DRAGHI, Deborah C; SAHM, Daniel F et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 3, pp 639-649, issn 0305-7453, 11 p.Article

Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiativeJONES, Mark E; KARLOWSKY, James A; BLOSSER-MIDDLETON, Renée et al.International journal of antimicrobial agents. 2002, Vol 19, Num 2, pp 119-123, issn 0924-8579Article

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the USKARLOWSKY, James A; DRAGHI, Deborah C; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2002, Vol 20, Num 2, pp 76-85, issn 0924-8579, 10 p.Article

Evaluation of current activities of Fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic SurveillanceSAHM, Daniel F; CRITCHLEY, Ian A; KELLY, Laurie J et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 267-274, issn 0066-4804Article

In vitro activity of telavancin against recent Gram-positive clinical isolates : results of the 2004-05 Prospective European Surveillance InitiativeDRAGHI, Deborah C; BENTON, Bret M; KRAUSE, Kevin M et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 1, pp 116-121, issn 0305-7453, 6 p.Article

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studiesKARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Clinical infectious diseases. 2005, Vol 40, pp S89-S98, issn 1058-4838, SUP2Article

Activities of faropenem, an oral β-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisCRITCHLEY, Ian A; KARLOWSKY, James A; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 550-555, issn 0066-4804Article

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVJONES, Mark E; CRITCHLEY, Ian A; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1651-1657, issn 0066-4804Article

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditorenKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 59-64, issn 0732-8893Article